Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand.

Autor: Chow KL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand; Department of Immunology, NSW Health Pathology, Newcastle, NSW, Australia. Electronic address: ke.chow@health.nsw.gov.au., Keating PE; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand., Solanki K; Department of Rheumatology, Waikato Hospital, Hamilton, New Zealand., Sapsford M; Department of Rheumatology, Middlemore Hospital, Auckland, New Zealand., Lindsay K; Department of Immunology, Auckland City Hospital, Auckland, New Zealand; Department of Rheumatology, Auckland City Hospital, Auckland, New Zealand., O'Donnell JL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand.

Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Oct; Vol. 68, pp. 152522. Date of Electronic Publication: 2024 Jul 14.

Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared to European populations in Aotearoa New Zealand.

Autor: Chow KL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand.; Department of Immunology, NSW Health Pathology, Newcastle, NSW, Australia., Keating PE; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand., O'Donnell JL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 25. Date of Electronic Publication: 2024 May 25.

HMGCR autoantibody testing: two tiers required.

Autor: Chow KL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand., Keating PE; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand., Spellerberg MB; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand., Chua I; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand., O'Donnell JL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand. Electronic address: john.odonnell@cdhb.health.nz.

Publikováno v: Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 129-131. Date of Electronic Publication: 2021 Jun 30.

Measurement of anti-natalizumab antibodies by homogeneous mobility shift assay.

Autor: Keating PE; Immunology Section, Canterbury Health Laboratories, Christchurch, New Zealand. Electronic address: paula.keating@cdhb.health.nz., Duncan R; Department of Neurology, University of Otago, Christchurch, New Zealand., Spellerberg M; Immunology Section, Canterbury Health Laboratories, Christchurch, New Zealand., O'Donnell J; Immunology Section, Canterbury Health Laboratories, Christchurch, New Zealand., Hock BD; Haematology Research Group, Christchurch Hospital, New Zealand.

Publikováno v: Pathology [Pathology] 2020 Apr; Vol. 52 (3), pp. 373-374. Date of Electronic Publication: 2020 Feb 26.

Epidemiology of myositis.

Autor: Duremala F; Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Alabama., Tiniakou E; Division of Rheumatology Medicine, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA., Andrews J; Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Alabama.

Publikováno v: Current opinion in rheumatology [Curr Opin Rheumatol] 2024 Dec 11. Date of Electronic Publication: 2024 Dec 11.